How does Dracocephalum moldavica work in the body?

Dracocephalum moldavica contains bioactive compounds including rosmarinic acid, luteolin, acacetin, apigenin, and ursolic acid. These flavonoids and phenolic acids exert antioxidant, anti-inflammatory, and mild sedative effects. Rosmarinic acid modulates inflammatory pathways, while flavonoids like apigenin interact with GABA receptors, contributing to the herb's anxiolytic and carminative properties. This mechanism supports its traditional use for digestive and nervous system complaints. Evidence level: C.

Does Dracocephalum moldavica interact with sedative medications?

Yes, Dracocephalum moldavica may potentiate the effects of sedative medications due to its mild central nervous system depressant properties. The herb contains flavonoids such as apigenin that enhance GABAergic activity. Concurrent use with benzodiazepines, barbiturates, or other sedatives may cause excessive drowsiness or enhanced sedation. Patients taking sedative medications should consult a healthcare provider before using this herb. Evidence level: C.

What is the recommended daily dosage of Dracocephalum moldavica for adults?

The typical adult dosage of Dracocephalum moldavica is 3-5 grams of dried herb daily, prepared as an infusion or decoction. Alternatively, 2-3 milliliters of tincture taken daily is commonly recommended. Dosage should be divided throughout the day and taken with meals to reduce potential gastric irritation. Individual responses may vary, and healthcare practitioner guidance is advised for optimal dosing. Evidence level: C/Traditional.

Is Dracocephalum moldavica safe to take during pregnancy?

No, Dracocephalum moldavica is considered unsafe during pregnancy. The herb contains compounds that may stimulate uterine contractions and should be avoided, particularly in large doses. Limited safety data exists for use during breastfeeding, so avoidance is recommended. Pregnant women or those planning pregnancy should consult a qualified healthcare provider before using any herbal preparations containing this herb. Evidence level: C.

What is Dracocephalum moldavica used for traditionally?

Dracocephalum moldavica has been traditionally used for digestive disorders including bloating, indigestion, and as a carminative to relieve gas. The herb is also employed for nervous conditions such as anxiety and headache relief. Its antimicrobial properties have been utilized in folk medicine for minor infections. The lemon-scented herb is native to Europe and Central Asia, where it has a history of use as a calming digestive aid. Evidence level: C/Traditional.

Dracocephalum moldavica (Dracocephalum moldavica)

PubMed-compiled information sheet

This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.

Compiled from 30 PubMed articles · model: gemma4:31b

Summary

Dracocephalum moldavica, also known as Moldavian balm or Xiang-qing-lan, is a medicinal and aromatic plant used traditionally in East Asia for cardiovascular and neurological conditions [PMID:37952760, PMID:32035879].

Background

Dracocephalum moldavica L. is an annual, herbaceous, balm-scented member of the Lamiaceae family widespread across the Northern Hemisphere [PMID:23411261, PMID:35406925]. It is utilized as a medicine, perfume, and ornamental plant [PMID:38921046].

Traditional uses

It is a traditional folk medicine used by Mongolian and Xinjiang Uyghurs to purge liver fire, clear stomach heat, and achieve hemostasis [PMID:37952760]. It is traditionally used for treating insufficient heart and blood, weakened brain function, spirit disease, migraines, and cardiovascular problems [PMID:37952760, PMID:32035879]. It is also used for improving the pharynx and relieving cough [PMID:36794391].

Active compounds

The plant contains essential oils (main components: geranyl acetate, geranial, and geraniol) [PMID:35406925, PMID:23411261]. Approximately 154 compounds have been identified, including flavonoids (e.g., tilianin), terpenoids (e.g., abietane diterpenoids dracocephalumoids A-E), lignans (e.g., dracomolphin A-E), phenylpropanoids, phenols (e.g., rosmarinic acid, caffeic acid, protocatechuic acid), and glycosides [PMID:37952760, PMID:33550196, PMID:33539939, PMID:28974807, PMID:36272140, PMID:37836602].

Mechanism of action

Total flavonoids (TFDM) may alleviate cognitive impairment and vascular dementia by modulating the TNF-α/NF-κB p65 signaling pathway, reducing neuronal damage, and improving blood-brain barrier integrity [PMID:40843367, PMID:34938197]. Tilianin suppresses NLRP3 inflammasome activation via inhibition of TLR4/NF-κB and NEK7/NLRP3 to mitigate myocardial ischemia-reperfusion injury [PMID:39508038]. Other mechanisms include activation of hippocampal ERK-CREB signaling for cognitive improvement [PMID:32035879], inhibition of the hedgehog signaling pathway to reduce pulmonary fibrosis [PMID:36794391], and upregulation of Kruppel-like factor 2 by moldavica acids A and B for potential atherosclerosis treatment [PMID:36272140].

Clinical evidence

Evidence DCognitive Impairment (Scopolamine-induced)

Ethanolic extract of leaves (25-100 mg/kg) significantly ameliorated cognitive impairment in mice [PMID:32035879]

Evidence DVascular Dementia (Rat model)

Total flavonoids (TFDM) attenuated memory deficits and reduced neuronal damage [PMID:40843367]

Evidence DMyocardial Ischemia-Reperfusion Injury (Rat model)

Tilianin (3-30 mg/kg) improved cardiac function and mitigated myocardial damage [PMID:39508038]

Evidence DPulmonary Fibrosis (Mouse model)

Total flavonoid extract (TFDM) improved lung function and reduced inflammatory factors [PMID:36794391]

Evidence DUlcerative Colitis (Rat model)

DML extract ameliorated colitis by improving disease activity index and modulating gut microbiota (increasing Lactobacillus) [PMID:37859616]

Evidence DChronic Mountain Sickness (Rat model)

Evidence summary

The current evidence consists primarily of in vitro studies and animal models (rats/mice), indicating strong pharmacological potential for anti-inflammatory, neuroprotective, and cardioprotective effects, but lacks human clinical trial data.

PubMed sources

1.PMID: 36272140 (2023) — Moldavica acid A, a new salicylic acid derivative from Dracocephalum moldavica. · Journal of Asian natural products research
2.PMID: 37952760 (2024) — Dracocephalum moldavica L.: An updated comprehensive review of its botany, traditional uses, phytochemistry, pharmacology, and application aspects. · Fitoterapia
3.PMID: 33312542 (2020) — Process optimization of spray-dried Moldavian balm (Dracocephalum moldavica L.) extract powder. · Food science & nutrition
4.PMID: 33550196 (2021) — Abietane diterpenoids from Dracocephalum moldavica L. and their anti-inflammatory activities in vitro. · Phytochemistry
5.PMID: 28974807 (2017) — Application of Moldavian dragonhead (Dracocephalum moldavica L.) leaves addition as a functional component of nutritionally valuable corn snacks.

Dracocephalum moldavica

Sources & Citations